(Q43225003)

16 November 2017

title

Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction (English)

1 reference

16 November 2017

5

1 reference

16 November 2017

9

1 reference

16 November 2017

Thipaporn Tharavanij

7

0 references

Shari Messinger Cayetano

series ordinal

3

object named as

Shari Messinger

1 reference

16 November 2017

2

Tatiana Froud

1 reference

16 November 2017

1

Raquel N Faradji

1 reference

16 November 2017

4

Kathy Monroy

1 reference

16 November 2017

6

Davide Mineo

1 reference

16 November 2017

Armando J Mendez

8

1 reference

16 November 2017

Rodolfo Alejandro

series ordinal

10

1 reference

16 November 2017

publication date

1 January 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

18

1 reference

16 November 2017

issue

10

1 reference

16 November 2017

page(s)

1247-1259

1 reference

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Second annual analysis of the collaborative islet transplant registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Simple measures to monitor beta-cell mass and assess islet graft dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Quality of life after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Amyloid and transplanted islets

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Consequences on beta-cell function and reserve after long-term pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Studies of pancreatic alpha cell function in normal and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

Amylin, released from the gastric fundus, stimulates somatostatin and thus inhibits histamine and acid secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368909X474456

21 January 2018

Identifiers

DOI

10.3727/096368909X474456

1 reference

16 November 2017

1 reference